Antifungal Susceptibility of the Aspergillus viridinutans Complex : Comparison of Two In Vitro Methods

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

5 Scopus Citations
View graph of relations

Author(s)

  • Pavlina Lyskova
  • Vit Hubka
  • Lucie Svobodova
  • Navneet K. Dhand
  • Takashi Yaguchi
  • Tetsuhiro Matsuzawa
  • Yoshikazu Horie
  • Miroslav Kolarik
  • Radim Dobias
  • Petr Hamal

Detail(s)

Original languageEnglish
Article numbere01927-17
Journal / PublicationAntimicrobial Agents and Chemotherapy
Volume62
Issue number4
Online published5 Feb 2018
Publication statusPublished - Apr 2018
Externally publishedYes

Abstract

Cryptic species of Aspergillus fumigatus, including the Aspergillus viridinutans species complex, are increasingly reported to be causes of invasive aspergillosis. Their identification is clinically relevant, as these species frequently have intrinsic resistance to common antifungals. We evaluated the susceptibilities of 90 environmental and clinical isolates from the A. viridinutans species complex, identified by DNA sequencing of the calmodulin gene, to seven antifungals (voriconazole, posaconazole, itraconazole, amphotericin B, anidulafungin, micafungin, and caspofungin) using the reference European Committee on Antimicrobial Susceptibility Testing (EUCAST) method. The majority of species demonstrated elevated MICs of voriconazole (geometric mean [GM] MIC, 4.46 mg/liter) and itraconazole (GM MIC, 9.85 mg/liter) and had variable susceptibility to amphotericin B (GM MIC, 2.5 mg/ liter). Overall, the MICs of posaconazole and the minimum effective concentrations of echinocandins were low. The results obtained by the EUCAST method were compared with the results obtained with Sensititre YeastOne (YO) panels. Overall, there was 67% agreement (95% confidence interval [CI], 62 to 72%) between the results obtained by the EUCAST method and those obtained with YO panels when the results were read at 48 h and 82% agreement (95% CI, 78 to 86%) when the results were read at 72 h. There was a significant difference in agreement between antifungals; agreement was high for amphotericin B, voriconazole, and posaconazole (70 to 86% at 48 h and 88 to 93% at 72 h) but was very low for itraconazole (37% at 48 h and 57% at 72 h). The agreement was also variable between species, with the maximum agreement being observed for A. felis isolates (85 and 93% at 48 and 72 h, respectively). Elevated MICs of voriconazole and itraconazole were cross-correlated, but there was no correlation between the other azoles tested. © 2018 American Society for Microbiology. All Rights Reserved.

Research Area(s)

  • amphotericin B, Aspergillus felis, Aspergillus udagawae, cryptic species, echinocandins, itraconazole, posaconazole, voriconazole

Citation Format(s)

Antifungal Susceptibility of the Aspergillus viridinutans Complex : Comparison of Two In Vitro Methods. / Lyskova, Pavlina; Hubka, Vit; Svobodova, Lucie; Barrs, Vanessa; Dhand, Navneet K.; Yaguchi, Takashi; Matsuzawa, Tetsuhiro; Horie, Yoshikazu; Kolarik, Miroslav; Dobias, Radim; Hamal, Petr.

In: Antimicrobial Agents and Chemotherapy, Vol. 62, No. 4, e01927-17, 04.2018.

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal